Vivos (RDGL) FCF Margin (2010 - 2025)
Vivos (RDGL) reported FCF Margin of 2179.84% for Q4 2025, up 724783.0% on a YoY basis from N/an in Q4 2024, and up 91.07% sequentially from 24400.27% in Q3 2025.
Vivos (RDGL) FCF Margin (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 15 years of FCF Margin data on file, last reported at 2179.84% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 724783.0% year-over-year to 2179.84%; the trailing twelve-month figure through Dec 2025 stood at 3009.32% (up 300618.0% YoY), and the FY2025 full-year result was 3160.22%, up 285528.0% from the prior year.
- FCF Margin rose to 2179.84% in Q4 2025, from 24400.27% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1196.2% in Q3 2021 to a low of 24400.27% in Q3 2025.
- A 5-year average of 5604.82% and a median of 4182.04% in 2022 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 724783 bps in 2025, while the deepest fall reached 1427513 bps in 2025.
- Tracing RDGL's FCF Margin over 5 years: stood at 1196.2% in 2021, then plunged by 262 bps to 4334.01% in 2022, then increased by 27 bps to 3170.33% in 2023, then tumbled by 197 bps to 9427.67% in 2024, then surged by 77 bps to 2179.84% in 2025.
- Business Quant data shows RDGL's FCF Margin at 2179.84% in Q4 2025, 24400.27% in Q3 2025, and 4030.07% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 37.67% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.18% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.68% |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -2,179.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,179.84% |
| Sep 30, 2025 | -24,400.27% |
| Jun 30, 2025 | -4,030.07% |
| Mar 31, 2025 | -1,701.80% |
| Dec 31, 2024 | -9,427.67% |
| Sep 30, 2024 | -10,125.14% |
| Jun 30, 2024 | -2,632.68% |
| Mar 31, 2024 | -7,810.18% |
| Sep 30, 2023 | -3,170.33% |
| Jun 30, 2023 | -4,835.97% |
| Mar 31, 2023 | -4,893.75% |
| Dec 31, 2022 | -4,334.01% |
| Sep 30, 2022 | -4,353.45% |
| Jun 30, 2022 | -1,629.70% |
| Mar 31, 2022 | -2,956.14% |
| Sep 30, 2021 | -1,196.20% |
| Sep 30, 2020 | -2,627.44% |
| Dec 31, 2019 | -16,877.13% |
| Sep 30, 2019 | -2,312.05% |
| Mar 31, 2017 | -6,868.72% |